Position in EOLS
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$4,763,058
-$439,669 QoQ
Shares Held
1,158,895
+48.1% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PINNACLE ASSOCIATES LTD holds $9,412,989 across 7 Drug Manufacturers - Specialty & Generic names. EOLS ranks #1 (50.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EOLS |
Evolus, Inc.
This page
|
1,158,895 | $4,763,058 | |
| 2 | ZTS |
Zoetis Inc.
|
18,117 | $2,141,610 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
22,707 | $1,345,843 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
854 | $506,404 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
5,484 | $303,320 | |
| 6 | VTRS |
Viatris Inc
|
13,981 | $188,883 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
59,807 | $163,871 |
All Filings in EOLS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,763,058 | 1,158,895 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $5,202,727 | 782,365 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,143,732 | 674,875 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,317,691 | 685,960 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||